Sarepta Therapeutics (SRPT) PT Slashed at Piper Sandler Following Survey Results
Tweet Send to a Friend
Piper Sandler analyst Biren Amin lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $110.00 (from $182.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
